Sartorius (OTCMKTS:SARTF) Hits New 12-Month High – Time to Buy?

Sartorius (OTCMKTS:SARTF – Get Free Report) shares hit a new 52-week high during mid-day trading on Friday. The stock traded as high as $261.9850 and last traded at $261.9850, with a volume of 1 shares trading hands. The stock had previously closed at $227.16.

Sartorius Trading Up 15.3%

The firm has a market cap of $8.97 billion, a P/E ratio of 121.85 and a beta of 0.98. The company’s 50 day simple moving average is $230.79 and its 200-day simple moving average is $222.00. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89.

Sartorius Company Profile

(Get Free Report)

Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services used in research, pharmaceutical development and biopharmaceutical manufacturing. Its offerings support laboratories and production facilities across the development cycle, from early-stage research and process development to commercial-scale manufacturing.

The company operates through its Lab Products & Services and Bioprocess Solutions divisions. Its products and services include laboratory instruments, balances, consumables, analytical systems, filtration technologies, bioreactors, cell culture equipment, single-use manufacturing components, software and related services.

See Also

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.